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Abstract
Introduction: Late presentation to HIV care leads to increased morbidity and mortality. We explored risk factors and reasons for
late HIV testing and presentation to care in the nationally representative Swiss HIV Cohort Study (SHCS).
Methods: Adult patients enrolled in the SHCS between July 2009 and June 2012 were included. An initial CD4 count B350 cells/ml
or an AIDS-defining illness defined late presentation. Demographic and behavioural characteristics of late presenters (LPs)
were compared with those of non-late presenters (NLPs). Information on self-reported, individual barriers to HIV testing and care
were obtained during face-to-face interviews.
Results: Of 1366 patients included, 680 (49.8%) were LPs. Seventy-two percent of eligible patients took part in the survey. LPs were
more likely to be female (pB0.001) or from sub-Saharan Africa (pB0.001) and less likely to be highly educated (p0.002) or men
who have sex with men (pB0.001). LPs were more likely to have their first HIV test following a doctor’s suggestion (p0.01), and
NLPs in the context of a regular check-up (p0.02) or after a specific risk situation (pB0.001). The main reasons for late HIV
testing were ‘‘did not feel at risk’’ (72%), ‘‘did not feel ill’’ (65%) and ‘‘did not know the symptoms of HIV’’ (51%). Seventy-one
percent of the participants were symptomatic during the year preceding HIV diagnosis and the majority consulted a physician for
these symptoms.
Conclusions: In Switzerland, late presentation to care is driven by late HIV testing due to low risk perception and lack of
awareness about HIV. Tailored HIV testing strategies and enhanced provider-initiated testing are urgently needed.
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Introduction
In Europe, over 50% of HIV-positive patients are late pre-
senters (LPs), defined as individuals presenting for HIV care
with a CD4 cell count below 350 cells/ml and/or an AIDS-
defining event (ADE) [1,2]. Late presentation to care is associ-
ated with increased morbidity, mortality and poor treatment
outcomes [35]. From a public health perspective, it con-
tributes to new HIV infections through individuals who are
unaware of their status [6] and causes avoidable healthcare
costs [7]. Late HIV diagnosis through late HIV testing has been
shown to be the main driver of late presentation to care;
delayed presentation after a positive test is considered less
important [2,8].
Numerous studies, including from the Swiss HIV Cohort
Study (SHCS) [9], have described demographic and structural
risk factors associated with late presentation to HIV care,
namely increased age, heterosexuality, low socio-economic
status, low literacy, high-prevalence country of origin and
the presence of logistic barriers [4]. Missed opportunities for
HIV testing, especially in patients presenting with suggestive
symptoms or indicator diseases, may also be an important
driver [10,11]. However, relatively little is known about
individual self-reported reasons for late presentation. A recent
systematic review identified only three studies that statisti-
cally evaluated psychosocial determinants of late presenta-
tion, two of them from Latin America [12]. In these small
studies, low risk perception, stigma, fear and psychosocial
distress were identified as potential sources of delayed testing
or limited health-seeking behaviour [1315]. These findings
may differ by geographic region and health system and need
to be confirmed in larger studies.
Despite increasing awareness of the main demographic
and clinical drivers of late presentation and existing initiatives
to address high-risk populations, late presentation remains
a significant problem even in settings with good access
to healthcare. In order to design and implement efficient
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strategies to tackle this problem, our understanding of the
individual reasons for late presentation must be improved.
We aimed to assess the prevalence of late presentation to
HIV care in Switzerland, a country with mandatory health
insurance for all official residents, and to identify related risk
factors, including structural, behavioural and psychological
barriers to HIV testing and linkage to care.
Methods
Swiss HIV Cohort Study
The SHCS (www.shcs.ch) is a prospective cohort study with
ongoing enrolment of HIV-positive adults in Switzerland. It
has remained representative of the HIV patient population
since its inception in 1988 and currently covers at least 56%
of the cumulative number of HIV-positive individuals the
Swiss public health authorities have been notified about,
71% of patients living with AIDS and 75% of those receiving
antiretroviral therapy (ART) [16]. Detailed information on
demographics, mode of HIV acquisition, risk behaviour, clinical
events, co-infections and treatment is collected at registration
and then at six-month intervals. Local ethical committees of
all participating study sites have approved the study and
written informed consent is obtained from all participants.
Study population and definitions
All adult patients newly included in the SHCS between 1 July
2009 and 30 June 2012 were analyzed. In line with the con-
sensus statement of the European Late Presenter Consensus
working group [1] we defined late presentation to HIV care as
having a first CD4 T-cell count B350 cells/ml and/or an ADE
within three months of presentation.The patients who did not
belong to this group were considered as non-late presenters
(NLPs). To describe specific patterns of late presentation to
care, we additionally sub-classified late presentation into two
groups according to the definitions proposed by Kozak et al.:
‘‘late HIV diagnosis’’ (or ‘‘late HIV testing’’) was defined
as having a CD4 cell count below 350 cells/ml within three
months of HIV diagnosis and ‘‘delayed presentation for HIV
care’’ as having a delay of more than three months between
the first positive HIV test and subsequent outpatient medical
visit [8]. Patients with known acute HIV infection at time
of presentation were classified as NLPs regardless of initial
CD4 cell count. All participants were included in the analyses
of demographic and clinical predictors of late presentation
for care. Additionally, all LPs as well as all NLPs from tertiary-
care hospitals (control group) were asked to participate in
a questionnaire-based survey on the individual HIV testing
circumstances and reasons for late presentation to care.
Questionnaire
To identify individual barriers to HIV diagnosis and care, we
designed a paper-based questionnaire to be completed by
all study patients agreeing to participate. Data were obtained
through face-to-face interviews using a standardized ques-
tionnaire in German, French or English. Interviews were con-
ducted by the treating physician or attending study nurse at
all but three study sites (Geneva, Lausanne and Aarau, where
questionnaires were completed by the patients themselves
and then discussed with a physician or study nurse). For
patients not fluent in any of the above languages, the
questionnaire was completed with the aid of a translator.
The questionnaire was based partially on a document from the
Denmark initiative (courtesy of Prof. Jens Lundgren, Copenhagen
HIV Programme, www.hiv-danmark.dk/fileadmin/user_upload/
hiv-danmark/pdf/Late_presenters-FINAL.pdf) and was adapted
to Swiss specificities. It included 43 questions on reasons
for and circumstances of HIV testing, behavioural risk factors,
patient awareness and knowledge of HIV, presence of symp-
toms and missed opportunities for HIV testing during the
12 months prior to referral for HIV care. The final part of the
questionnaire was dedicated to LPs and assessed individual
reasons for late testing and delayed presentation to care.
When applicable, reasons for not completing the question-
naire were documented. An initial evaluation of the ques-
tionnaire data was performed in the context of a pilot study in
Zurich [17]. This report did not include data from interviews
with patients but assessed the relevance of the questions in
a chart review.
Statistical analyses
Differences in demographic, behavioural and clinical char-
acteristics between LPs and NLPs were assessed using
the Mann-Whitney and chi-square tests for continuous and
categorical variables, respectively. Education level was de-
fined as high if tertiary education was completed. Survey
data from paper-based questionnaires were managed with
REDCap (Research Electronic Data Capture) electronic data
capture tools (www.redcap.vanderbilt.edu/) [18]. The most
frequent reasons for testing were described in percentages
and compared between LPs and NLPs using the chi-square
test. Finally, we evaluated the main self-reported reasons
for late presentation to care among LPs. All statistical ana-
lyses were performed with Stata 12.1 (StataCorp 2012, Stata
Statistical Software, College Station, TX, USA).
Sensitivity analysis
Patients with an unrecognized acute HIV infection may have a
low CD4 cell count or an ADE at presentation. In order to avoid
misclassification of these patients into the LP category, we
repeated our analyses after excluding patients with an acute
infection according to the ambiguity score, recently described
by Kouyos et al. [19] and subsequently validated [20,21]. This
score provides information on the individual duration of HIV
infection by determining the fraction of ambiguous nucleo-
tides in the viral pol sequences and helps classify primary
HIV infections. Genetic information to perform these analyses
was derived from the genotypic resistance tests routinely
performed at SHCS enrolment.
Results
Study population and baseline characteristics of LPs
During the study period, 1366 patients were enrolled in the
SHCS, of whom 680 (49.8%) were LPs (Figure 1).
Among LPs, 636 (93.5%) had a CD4 count below 350 cells/ml
and 215 (31.6%) an ADE; 347 (51.0%) had a CD4 count below
200 cells/ml. Forty-four of 215 patients with an ADE presented
with a CD4 count of]350 cells/ml. Themost commonADEswere
Pneumocystis jirovecii pneumonia (65 cases, 30.2%), pulmonary
tuberculosis (22 cases, 10.2%) and Kaposi’s sarcoma (22 cases,
10.2%). Thirty-four individuals with a known primary infection,
Hachfeld A et al. Journal of the International AIDS Society 2015, 18:20317
http://www.jiasociety.org/index.php/jias/article/view/20317 | http://dx.doi.org/10.7448/IAS.18.1.20317
2
presenting with a CD4 count below 350 cells/ml or an ADE
at diagnosis, were reclassified as NLPs. The proportion of
LPs differed slightly between the SHCS centres, ranging from
44.4% in Zurich to 58.6% in Basel. Compared to NLPs, LPs were
more likely to be male and heterosexual (29.1% vs. 18.6%) or
female (30.0% vs. 20.0%) and to originate from sub-Saharan
Africa (18.6% vs. 10.1%) or Asia (7.5% vs. 2.5%). NLPs were
more likely to be men who have sex with men (MSM) (61.4%
vs. 40.9%) and to have high-level education (43.4% vs. 35.6%)
(Table 1).
Questionnaire completion
Of 1366 patients enrolled, 297 NLPs from private practices
were excluded from the survey for logistical reasons (Figure 1).
Figure 1. Flow chart of late presenter survey.
ADE, AIDS-defining event.
Table 1. Demographic characteristics of late and non-late presenters
Late presenters Non-late presenters
N680 (49.8%) N686 (50.2%) p
Demographic group (%) B0.001
MSM 278 (40.9) 421 (61.4)
Non-MSM male 198 (29.1) 128 (18.6)
Female 204 (30.0) 137 (20.0)
Median age in years (IQR) 40.6 (32.748.4) 38.2 (31.045.4) B0.001
Median first CD4 count in cells/ml (IQR) 195 (88286) 511 (417663) B0.001
Region of origin (%) B0.001
SouthNorthwest Europe 435 (64.0%) 515 (75.3%)
Sub-Saharan Africa 126 (18.6%) 69 (10.1%)
SouthEast Asia 51 (7.5%) 17 (2.5%)
Other 67 (9.9%) 83 (12.1%)
High-level education (%) 242 (35.6%) 297 (43.4%) 0.002
IQR, interquartile range; MSM, men who have sex with men.
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Of the 1069 remaining patients, 766 (71.6%) completed the
questionnaire. The main reasons for not completing the
questionnaire are shown in Figure 1. Although patients who
completed the questionnaire were slightly older (median age
40.5 vs. 38.4, p0.02) and comprised more individuals of
European origin (71.0% vs. 59.0%, pB0.01) than those who
did not complete the questionnaire (Supplementary Table 1),
there was no difference in the proportion of late presentation
to care between these two groups (64.9% vs. 59.1%, p0.08).
Behavioural and clinical differences between
late and NLPs
Compared to NLPs, LPs were more likely to be diagnosed with
HIV during hospitalization (21.8% vs. 8.8%, pB0.01) and less
likely to be aware of the place of infection (23.1% vs. 15.5%,
pB0.01) or to remember a specific risk situation that could
have led to infection (33.9% vs. 50.6%, pB0.01) (Table 2).
Although the majority of patients had a stable relationship
at time of diagnosis, 51.3% of LPs and 61.9% of NLPs had
occasional sexual partners and over three-quarters of them
reported inconsistent condom use. Of all patients, 71% had
symptoms during the 12 months prior to diagnosis. This
proportion was slightly higher in LPs compared to NLPs (73.3%
vs. 66.8%, p0.06). The most common symptoms were
fatigue, fever and weight loss, each of which affected over
20% of the study population. Fatigue, weight loss and skin
or oral lesions were more common among LPs (all pB0.05)
(Table 2). Overall, 50.7% of LPs versus 38.4% of NLPs
(pB0.01) exhibited at least one of these four manifestations.
Of the symptomatic patients, 74.2% sought medical care
because of symptoms, and over two-thirds had a general
practitioner (GP) at the time of HIV diagnosis.
Reasons for HIV testing
The most frequent reasons for HIV testing are shown in
Figure 2.
‘‘Doctor’s suggestion’’ was the most frequent overall
(n178, 23.2%), followed by ‘‘symptoms’’ (n176, 23.0%),
‘‘regular check-up’’ (n115, 15.0%) and ‘‘specific risk situa-
tion’’ (n105, 13.7%). Few patients had their first positive
test in the context of a pregnancy (n30, 4.0%) or because of
a positive partner (n36, 4.7%). Similar proportions of LPs
and NLPs reported having undergone their first positive HIV
test due to relevant symptoms or because they had a new
partner. However, LPs were significantly more likely to test
following a doctor’s suggestion (provider-initiated testing)
Table 2. Behavioural and clinical determinants of late presentation to care according to questionnaire data
Late presenters Non-late presenters Total
(N501) (N265) (N766) p
First positive test during hospitalization (%) 104 (21.8) 22 (8.8) 126 (17.3) B0.001
Place of infection (%) B0.001
Switzerland 193 (40.6) 138 (55.4) 331 (45.7)
Abroad 164 (34.5) 76 (30.5) 240 (33.1)
Unknown 119 (25.0) 35 (14.1) 154 (21.2)
Remembers specific risk situation (%) 160 (33.9) 126 (50.6) 286 (39.7) B0.001
Stable relationship (%)a 288 (60.4) 133 (52.8) 415 (57.8) 0.05
Occasional sex partners (%)a 242 (51.3) 154 (61.9) 396 (54.9) 0.01
Inconsistent condom use (%)a 331 (79.4) 173 (75.6) 504 (78.0) 0.26
Symptomsb
At least one symptom 366 (73.3) 177 (66.8) 544 (71.0) 0.06
Fatigue 175 (34.9) 71 (26.8) 246 (32.1) 0.02
Fever 123 (24.6) 73 (27.6) 196 (25.6) 0.37
Weight loss 142 (28.3) 26 (9.8) 168 (21.9) B0.001
Respiratory infection 102 (20.4) 46 (17.4) 148 (19.3) 0.32
Skin lesions 91 (18.2) 28 (10.6) 119 (15.5) 0.01
Diarrhoea 85 (17.0) 34 (12.8) 119 (15.5) 0.13
Lymphadenopathy 73 (14.6) 45 (17.0) 118 (15.4) 0.38
Oral lesions 63 (12.6) 19 (7.2) 82 (10.7) 0.02
Muscle pain 45 (9.0) 24 (9.1) 69 (9.0) 0.97
At least one of the following symptoms: fatigue, weight loss,
oral or skin lesions
254 (50.7) 102 (38.5) 356 (46.5) 0.001
Had a GP at time of diagnosis 315 (66.2) 173 (68.9) 488 (67.1) 0.45
Consultation for symptoms 234 (74.8) 108 (73.0) 342 (74.2) 0.68
GP: general practitioner.
aDuring the six months before diagnosis; bduring the 12 months before diagnosis;
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compared to NLPs. In contrast, NLPs tested more often
because of a specific risk situation or in the context of a
regular check-up (Figure 2).
Reasons for late HIV testing
Only 8.9% of patients reported waiting more than three
months after their HIV diagnosis before presenting for medical
care (delayed presentation). However, of the 501 LPs who
completed the questionnaire, 236 (47.1%) stated that they
realized they had not tested early enough. The most frequent
self-reported reasons for testing late in these patients are
summarized in Figure 3.
The majority of these individuals (72.3%) did not feel they
were at risk of being infected with HIV and most of them
(64.7%) did not test because they did not feel ill. Reasons
linked to the lack of knowledge about HIV were also prevalent:
many patients did not know the symptoms of HIV infection
(51%) or were not aware of treatment (48%) or anonymous
testing possibilities (30%). One-quarter thought there was no
benefit in knowing their HIV status. Finally, reasons related to
fear were also important: 48.6% were afraid to find out about
a possible HIV infection, 39% feared their relatives’ reactions
and 26.0% their partner’s reactions.
Sensitivity analysis
Among the LP group, 298/501 individuals (59.5%) had an
ambiguity score available. Of these, 80 (27.5%) had a low
score, suggesting recent infection. Excluding these patients
from the analyses did not significantly alter the proportion of
LPs and NLPs diagnosed during hospitalization, being aware
of the place of infection or specific risk situations or being
symptomatic before HIV diagnosis. The main reasons for HIV
Figure 2. Main reasons for HIV testing among 501 late presenters and 265 non-late presenters.
(Reason explanations: ‘‘doctor,’’ tested after doctor’s suggestion; ‘‘symptoms,’’ tested because of relevant symptoms; ‘‘check-up,’’ tested in the
context of a regular check-up; ‘‘risk situation,’’ tested after experiencing a risk situation; ‘‘new partner,’’ tested after starting a new relationship.)
Figure 3. Reasons for late HIV testing among 236 late presenters.
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testing and the causes for late testing in LPs were also
comparable to the main analyses (data not shown).
Discussion
Despite the widespread availability of ART and good access
to medical care, late presentation to care remains one of
the biggest challenges in the management of HIV infection in
high-income countries. Nearly half of the 1366 patients in
our study were LPs. This trend was driven mainly by late HIV
testing due to low risk perception and lack of awareness of
HIV transmission, symptoms and treatment. LPs were more
likely to be heterosexual, originating from sub-Saharan Africa
and to have undergone the first positive test during a hos-
pitalization or upon a doctor’s suggestion. In contrast, NLPs,
with amajority ofMSM,more often had their first positive test
during a regular check-up or in the context of a specific risk
situation. These results illustrate the differences between LPs
and NLPs in terms of demographic and behavioural character-
istics, as well as HIV risk perception, and underline the need
for targeted public health and communication strategies to
enhance HIV testing in populations at high risk of late
presentation.
The proportion of LPs observed in our study (49.8%) was
similar to recent studies from Denmark [11] and Germany
[22], but marginally lower than that reported in COHERE, a
large European HIV cohort collaboration (53.8%) [2]. As there
was a decrease in LP prevalence from 57.3% in 2000 to 51.7%
in 2010/2011 in COHERE, our result could be explained by
a slow, general improvement in early HIV testing and care in
Europe. This hypothesis is also strengthened by the compar-
ison of our results with previous data from the SHCS [9]:
between 1998 and 2007, 31% of patients presented with CD4
B200 cells/ml and/or AIDS, whereas this proportion was 19%
during our study period (2009 to 2012). The variability of the
proportion of LPs between SHCS sites was driven potentially
by differences in patient demographic characteristics: Zurich,
for instance, with the lowest LP prevalence, had the highest
proportion of MSM. In line with most published studies, the
main demographic factors associated with late presentation
to HIV care in our study were heterosexuality, female sex,
increased age, low education and sub-Saharan African origin.
To understand the principal determinants of late presenta-
tion to care, it is necessary to look beyond patient demo-
graphic characteristics. Among the few studies that have
described structural and social predictors of late presentation,
Delpierre and colleagues showed that late presentation in
France was associated with ‘‘living as part of a couple with
children’’ [5]. The finding that LPs in the SHCS were also more
likely to live in a stable partnership compared to NLPs confirms
that late presentation is more prevalent in patient categories
not traditionally considered high risk for HIV infection. HIV
risk perception in our study was lower among LPs than NLPs:
LPs were more often diagnosed during hospitalization and less
likely to remember the place of infection or a specific situation
that may have led to the infection. There were also large
differences in the main reasons for HIV testing between LPs
and NLPs: LPs were more likely to perform the first HIV test
upon a doctor’s suggestion whereas NLPs tested more regu-
larly during routine check-ups or after specific risk situations.
Thus, the description of the context in which patients under-
went their first positive HIV test underlined the lack of
awareness of HIV risk in LPs and the importance of provider-
initiated HIV testing in this population.
Previous reports have shown that late presentation to HIV
care was driven almost exclusively by late HIV testing and that
delayed presentation after a positive HIV test was was true
for only a fraction of these patients [2]. Our data confirm
these findings: 9% of LPs reported having waited over three
months to seek medical care after their first positive test.
In contrast, approximately one-half of LPs admitted to having
performed their first HIV test too late. Patterns of late pre-
sentation to care might differ in countries where access to
HIV medical care is difficult for some populations. In a recent
study from New York City of 1928 patients with newly
diagnosed HIV infection, only 63.7% were linked to medical
care within three months after their positive test [23]. The
two most common self-reported reasons for late HIV testing
among LPs in our study were ‘‘I did not feel at risk’’ and ‘‘I did
not feel ill.’’ As reported in a previous study from South
America [13], this shows that low perception of HIV risk was
also a major driver of late presentation to care in our setting.
The fact that many LPs recalled having relevant symptoms and
a GP at the time of HIV diagnosis but still did not feel at risk of
infection also highlights differences in health perception and
health-seeking behaviour, which may vary with origin and
socio-cultural background [24]. Finally, reasons relating to lack
of knowledge regarding HIV infection in our study were repor-
ted more frequently than those linked to fear and discrimi-
nation, which might be more prevalent in resource-limited
settings [25].
To our knowledge, this is the first study to assess demo-
graphic, socio-economic and behavioural risk factors for
late presentation to HIV care in a nationwide cohort. Further-
more, our detailed questionnaire allowed identification of
the circumstances in which patients performed their first
positive HIV test and the main reasons for late HIV testing.
The combination of routine HIV care data and information
from a dedicated survey allowed us to create a unique data-
set dedicated to the study of the main determinants of
late presentation to care. However, we acknowledge several
limitations. The group of patients who presented late accord-
ing to the definition proposed by European Late Presenter
Consensus working group [1] included a number of indi-
viduals with primary or early HIV infection. We addressed
this challenge in two ways. First, we reclassified 34 patients
with low CD4 counts and known primary infection into the
NLP category. Second, we repeated our main analyses after
excluding individuals with possible early infection according
to their ambiguous nucleotide score [19], a measure that
was shown to identify false LP in a previous analysis from a
subset of the SHCS [17]. This step afforded a more accurate
picture of late presentation to care in our study compared
to previous reports. Another limitation was the survey par-
ticipation rate, with approximately one-quarter of eligible
patients declining or being unable to complete the ques-
tionnaire. Against this, the baseline characteristics of patients
with and without questionnaire data were similar, suggesting
that incomplete participation did not bias our observations.
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Finally, as with any survey, reporting and recall biases may
have influenced the data collected.
In summary, in this nationwide HIV cohort, late presenta-
tion to care was more frequent in patients from sub-Saharan
Africa and Asia and in those not traditionally considered
at high risk. Insufficient awareness regarding HIV trans-
mission and symptoms were the most important drivers of
late testing. Given the economic and health consequences of
late presentation to care, healthcare workers and public
health authorities need to improve HIV testing strategies
and elaborate methods for increasing testing during early
infection in specific populations, notably patients from sub-
Saharan Africa and married couples. To date, there is still no
free and anonymous HIV testing platform in Switzerland,
and specific health structures have been developed mostly
for MSM. Most LPs have a GP, experience symptoms during
the year preceding the HIV diagnosis and consult a doctor
for these symptoms. These missed opportunities for earlier
diagnosis need to be addressed by enhancing provider-
initiated testing. Primary care and specialist physicians need
to increase HIV testing among their patients if earlier diagnosis
and linkage to care are to be achieved.
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